electroCore, Inc.

ECOR Medical devices

Develops non-invasive vagus nerve stimulators for headache and fibromyalgia.

Jun 2026Revenue $37.0M/yrExpenses $50.9M/yr
Expected break-even Apr 2031Cash runway ≈ 1.0 years from Jun 2026
Figures by year

When will electroCore be profitable?

Its revenue and expense trends are projected to cross in Apr 2031. In the 12 months to Jun 2026, revenue was $37.0M and expenses $50.9M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$32.0M$45.2M−$13.2M
Dec 2024$25.2M$37.3M−$12.2M
Dec 2023$16.0M$35.3M−$19.3M
Dec 2022$8.59M$31.5M−$22.9M
Dec 2021$5.45M$25.5M−$20.0M
Dec 2020$3.50M$28.2M−$24.7M
Dec 2019$2.39M$48.5M−$46.1M
Dec 2018$993K$55.5M−$54.6M
Dec 2017$811K$26.5M−$25.6M